Open in App
  1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : PHARMACEUTICALS
  4. SYNCOM FORMULATION (INDIA) LTD.
Syncom Formulation (India) Ltd.
NSE: SYNCOMF | BSE: 524470 | ASM

Syncom Formulation Live Share Price Today, Share Analysis and Chart

Strong Performer, Getting Expensive
about

Syncom Formulations (India) Limited is a pharmaceutical organization involved in the manufacturing and marketing of a diverse range of pharmaceutical formulations. The company serves both domestic and international markets, offering a portfolio that ...

Read More
Ask AI about Syncom Formulation
20.14 -0.83 (-3.96%)
New 52W High in past week
7.0M
NSE+BSE Volume

NSE 09 Sep, 2026 3:31 PM (IST)

Watchlist

Portfolio

Alert
Dividend
Syncom Formulation has an upcoming dividend of ₹0.100 per share due on 23 Sep 2026 See details
Loading... You have run out of DVM views!
Subscribe now to see details
Durability score
High Financial Strength
- / 100
Valuation Score
Mid Valuation
- / 100
Momentum Score
Technically Bullish
72.7 / 100
Strong Performer, Getting Expensive These stocks are strong in quality and technicals but have medium valuation. At somewhat expensive valuations, investors should be cautious before buying View Similar Embed DVM
Analyst Price Target
No estimates available

31

S

3

W

4

O

0

T

SWOT Analysis

Syncom Formulation Live Price Chart

Switch to TradingView
Switch to

Syncom Formulation Live Price Chart

Custom


Loading Fundamental data..


Loading data..
Is Syncom Formulation (India) Ltd. worth buying?
936 Votes:
Buy 83.87%
Sell 8.12%
Hold 8.01%
BUY
SELL
HOLD
Ask AI
×